We assume that the ability of normal cells to convert menadione to vitamin K2 (which has a membrane binding tail) is diminished or absent for cancer cells due to the downregulation of UBIAD1 (TERE1) [92, 93]. This evidence concerns the gene UBIAD1 and cancer.